These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1645431

  • 1. Rapid changes in the content of proenkephalin A and corticotrophin releasing hormone mRNAs in the paraventricular nucleus during morphine withdrawal in urethane-anaesthetized rats.
    Harbuz M, Russell JA, Sumner BE, Kawata M, Lightman SL.
    Brain Res Mol Brain Res; 1991 Mar; 9(4):285-91. PubMed ID: 1645431
    [Abstract] [Full Text] [Related]

  • 2. Corticotrophin-releasing hormone, proenkephalin A and oxytocin mRNA's in the paraventricular nucleus during pregnancy and parturition in the rat.
    Douglas AJ, Russell JA.
    Gene Ther; 1994 Mar; 1 Suppl 1():S85. PubMed ID: 8542431
    [Abstract] [Full Text] [Related]

  • 3. RU-486 blocks stress-induced enhancement of proenkephalin gene expression in the paraventricular nucleus of rat hypothalamus.
    García-García L, Harbuz MS, Manzanares J, Lightman SL, Fuentes JA.
    Brain Res; 1998 Mar 09; 786(1-2):215-8. PubMed ID: 9555022
    [Abstract] [Full Text] [Related]

  • 4. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.
    Lightman SL, Young WS.
    J Physiol; 1988 Sep 09; 403():511-23. PubMed ID: 3267021
    [Abstract] [Full Text] [Related]

  • 5. Effect of naloxone-precipitated morphine withdrawal on CRH and vasopressin mRNA expression in the rat hypothalamic paraventricular nucleus.
    Milanés MV, Laorden ML, Angel E, Tankosic P, Burlet A.
    Neurosci Lett; 2002 Dec 06; 334(1):58-62. PubMed ID: 12431775
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA.
    Harbuz MS, Lightman SL.
    Neuropeptides; 1989 Jul 06; 14(1):17-20. PubMed ID: 2789345
    [Abstract] [Full Text] [Related]

  • 7. Stress responsiveness of hypothalamic corticotrophin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat.
    Harbuz MS, Nicholson SA, Gillham B, Lightman SL.
    J Endocrinol; 1990 Dec 06; 127(3):407-15. PubMed ID: 2280210
    [Abstract] [Full Text] [Related]

  • 8. Release of oxytocin into blood and into cerebrospinal fluid induced by naloxone in anaesthetized morphine-dependent rats: the role of the paraventricular nucleus.
    Coombes JE, Robinson IC, Antoni FA, Russell JA.
    J Neuroendocrinol; 1991 Oct 01; 3(5):551-61. PubMed ID: 19215505
    [Abstract] [Full Text] [Related]

  • 9. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP, Wiegand SJ, Watson SJ.
    Endocrinology; 1990 Nov 01; 127(5):2408-17. PubMed ID: 2171915
    [Abstract] [Full Text] [Related]

  • 10. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
    McNally GP, Akil H.
    Neuroscience; 2002 Nov 01; 112(3):605-17. PubMed ID: 12074902
    [Abstract] [Full Text] [Related]

  • 11. Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus.
    Sarkar S, Légrádi G, Lechan RM.
    Brain Res; 2002 Jul 26; 945(1):50-9. PubMed ID: 12113951
    [Abstract] [Full Text] [Related]

  • 12. Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala.
    Hamlin AS, Buller KM, Day TA, Osborne PB.
    Neurosci Lett; 2004 May 13; 362(1):39-43. PubMed ID: 15147776
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat.
    Aguilera G, Jessop DS, Harbuz MS, Kiss A, Lightman SL.
    J Endocrinol; 1997 May 13; 153(2):185-91. PubMed ID: 9166107
    [Abstract] [Full Text] [Related]

  • 14. Release of oxytocin but not corticotrophin-releasing factor-41 into rat hypophysial portal vessel blood can be made opiate dependent.
    Sheward WJ, Coombes JE, Bicknell RJ, Fink G, Russell JA.
    J Endocrinol; 1990 Jan 13; 124(1):141-50. PubMed ID: 2299273
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug 13; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint.
    Ma XM, Lightman SL, Aguilera G.
    Endocrinology; 1999 Aug 13; 140(8):3623-32. PubMed ID: 10433220
    [Abstract] [Full Text] [Related]

  • 17. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II.
    Aguilera G, Young WS, Kiss A, Bathia A.
    Neuroendocrinology; 1995 Apr 13; 61(4):437-44. PubMed ID: 7783857
    [Abstract] [Full Text] [Related]

  • 18. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
    Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S.
    Neuroendocrinology; 2001 May 13; 73(5):293-301. PubMed ID: 11399902
    [Abstract] [Full Text] [Related]

  • 19. Effects of a specific glucocorticoid receptor antagonist on corticotropin releasing hormone gene expression in the paraventricular nucleus of the neonatal rat.
    Yi SJ, Masters JN, Baram TZ.
    Brain Res Dev Brain Res; 1993 Jun 08; 73(2):253-9. PubMed ID: 8353935
    [Abstract] [Full Text] [Related]

  • 20. Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating hormone-induced cyclic adenosine 5'-monophosphate response element binding protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and increases CREB phosphorylation in corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.
    Sarkar S, Lechan RM.
    Endocrinology; 2003 Jan 08; 144(1):281-91. PubMed ID: 12488356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.